BackImmunoPrecise Antibodies Overview

ImmunoPrecise Antibodies Other Current Assets

Track ImmunoPrecise Antibodies's other current assets ($1.3M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$1.25M
↑ 20.32% YoYΔ $211718.00 vs prior year quarter

Peer average

Loading

ImmunoPrecise Antibodies Other Current Assets History

Loading

ImmunoPrecise Antibodies vs. peers: Other Current Assets Comparison

Loading

ImmunoPrecise Antibodies Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

ImmunoPrecise Antibodies (IPA) FAQ

As of the most recent data (January 2026), IPA shows a other current assets of $1.3M. That compares with $1M in the prior-year period — up 20.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, IPA's other current assets is now $1.3M (was $1M) — a 20.3% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ImmunoPrecise Antibodies is outperforming or lagging.

Tracking IPA's other current assets over time shows whether ImmunoPrecise Antibodies is scaling, shrinking, or reshaping that part of the business. The current reading is $1.3M That compares with $1M in the prior-year period — up 20.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other current assets page, Stockcircle has ImmunoPrecise Antibodies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other current assets (currently $1.3M) with ownership activity and broader fundamentals.

ImmunoPrecise Antibodies's other current assets is $1.3M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.